ClinicalTrials.Veeva

Menu

Chronic Inflammation and Exercise Responsiveness

Mayo Clinic logo

Mayo Clinic

Status

Completed

Conditions

Metabolic Syndrome

Study type

Observational

Funder types

Other

Identifiers

NCT02732509
16-000437

Details and patient eligibility

About

The purpose of this study is to determine how chronic inflammation influences skeletal muscle protein metabolism and metabolic function in humans. The investigators will evaluate acute responsiveness to a single bout of exercise in men and women who are either lean or overweight/obese. The investigators will explore the relationship between circulating inflammatory markers and anabolic, proteomic, and transcriptional responses to acute exercise. The investigators will measure skeletal muscle protein synthesis in the postabsorptive state and in response to a single bout of exercise.

Enrollment

146 patients

Sex

All

Ages

30 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 30-55 years
  • BMI 19-45 kg/m2

Exclusion criteria

  • Anemia (female subjects hemoglobin of <11 g/dl and male subjects hemoglobin <12 g/dl)
  • Active coronary artery disease or history of unstable macrovascular disease (unstable angina, myocardial infarction, stroke, and revascularization of coronary, peripheral or carotid artery within 3 months of recruitment)
  • Renal insufficiency/failure (serum creatinine > 1.5mg/dl)
  • Oral warfarin group medications or history of blood clotting disorders.
  • Pregnancy or breastfeeding
  • Alcohol consumption greater than 2 glasses/day or other substance abuse
  • Untreated or uncontrolled thyroid disorders
  • Debilitating chronic disease (at the discretion of the investigators)

Trial design

146 participants in 2 patient groups

Lean
Description:
Body mass index less than 25 kg/m2
Overweight/obese
Description:
Body mass index 25-45 kg/m2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems